Literature DB >> 22493044

Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus.

J Kline1, A Kinney, S Brown, B Levin, K Oppenheimer, D Warburton.   

Abstract

BACKGROUND: We hypothesized that trisomy arises as a function of the size of the oocyte pool, with risk increased among women with diminished pools. Diminished pools may cause primary ovarian failure, which has been associated with premutation and intermediate CGG repeat length at the Fragile X mental retardation (FMR1) locus. Thus, we hypothesized that the risk of trisomic pregnancy is increased among women with intermediate CGG repeat length on the FMR1 gene.
METHODS: The analysis drew on data from two hospital-based case-control studies. We compared 207 women with trisomic spontaneous abortions (SAs) to three comparison groups: 82 women with other chromosomally abnormal SAs, 99 women with chromosomally normal SAs and 537 women with live births (LBs), age matched to women with SAs. We defined the length of the CGG repeat in four ways: the biallelic mean, the genotypic mean, the length on allele 2 and the length on allele 1. We analyzed CGG repeat length as a categorical variable. All analyses were adjusted for site, age and ethnicity.
RESULTS: CGG repeat length did not differ significantly between women with trisomic SAs and any of the three comparison groups. For the biallelic mean, the adjusted odds ratio relating trisomy (versus LB controls) to the highest category (35.5-59.5 repeats) versus the modal category (26.5-30.0 repeats) was 1.5 (95% confidence interval (CI): 0.7, 3.1). Comparisons with the two SA control groups also showed increased odds of more repeats among trisomy cases. Results were similar when repeat length was defined by the genotypic mean or by the repeat length on allele 2. For allele 1, the odds of short (9-19) repeat length were lower, but not significantly so, for trisomy cases compared with LB controls. Excluding women with premutations (n= 2) from the analysis yielded an adjusted odds ratio of 1.4 (95% CI: 0.7, 2.9) for the biallelic mean.
CONCLUSIONS: Our data are equivocal. The direction of associations is consistent with the hypothesis that repeat length in the intermediate range is associated with trisomy. However, differences between the trisomy cases and the comparison groups are neither large nor statistically significant. Our data rule out odds ratios larger than about 3.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22493044      PMCID: PMC3619969          DOI: 10.1093/humrep/des098

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  35 in total

1.  Trisomic pregnancy and earlier age at menopause.

Authors:  J Kline; A Kinney; B Levin; D Warburton
Journal:  Am J Hum Genet       Date:  2000-06-28       Impact factor: 11.025

2.  Are elevated FSH concentrations in the pre-conceptional period a risk factor for Down's syndrome pregnancies?

Authors:  J M van Montfrans; C B Lambalk; M H van Hooff; J M van Vugt
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

3.  Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.

Authors:  R D L Hundscheid; A P T Smits; C M G Thomas; L A L M Kiemeney; D D M Braat
Journal:  Am J Med Genet A       Date:  2003-02-15       Impact factor: 2.802

4.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.

Authors:  A Kenneson; F Zhang; C H Hagedorn; S T Warren
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

5.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

6.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

7.  Reproductive and menstrual history of females with fragile X expansions.

Authors:  A Murray; S Ennis; F MacSwiney; J Webb; N E Morton
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

8.  The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter.

Authors:  Li-Sheng Chen; Flora Tassone; Parminder Sahota; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2003-09-30       Impact factor: 6.150

9.  Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.

Authors:  Beatrice Primerano; Flora Tassone; Randi J Hagerman; Paul Hagerman; Francesco Amaldi; Claudia Bagni
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

Review 10.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

View more
  3 in total

1.  Are expanded alleles of the FMR1 gene related to unexplained recurrent miscarriages?

Authors:  M Fragkos; H Bili; D Ntelios; G Tzimagiorgis; B C Tarlatzis
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

2.  Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age.

Authors:  Jennie K Kline; Ann M Kinney; Bruce Levin; Stephen A Brown; Andrew G Hadd; Dorothy Warburton
Journal:  Menopause       Date:  2014-07       Impact factor: 2.953

3.  Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Srinivasan Muthuswamy
Journal:  J Assist Reprod Genet       Date:  2019-10-17       Impact factor: 3.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.